Catalyst
Slingshot members are tracking this event:
PTC Therapeutics Announces Presentation of Results from Phase 3 ACT DMD Clinical Trial of Translarna (ataluren) in Patients with Duchenne Muscular Dystrophy at 5th International Congress of Myology
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTCT | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 14, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Translarna, Ataluren, Phase 3 Act Dmd Trial, Nmdmd, Protein Restoration
